North America Primed for Pet Insurance Market Expansion and Expecting $1.1 Billi... (on this report from Packaged Facts visit...)

(Date:1/8/2009)...Newswire-USNewswire/ -- The Pew Charitable Trusts ...director, chemical and food safety programs, in it...n, who was formerly deputy staff director and gene... and Public Works, brings nearly 25 years of exper...y to Pew. , , "We are excited to be joined by ...

(Date:1/8/2009)...RNewswire-FirstCall/ -- Cephalon, Inc . (Nasdaq: ...Ph.D., Chairman and CEO will present at the J.P. ...y 13, 2009 in San Francisco, CA at approximately 4...resentation will be webcast live on the investor r... The webcast will be archived for one week followi...

(Date:1/8/2009)...8 Heska Corporation (Nas... , , What: Heska Corporation Invites You...r-End 2008 Earnings Conference Call on the Web,...MST], Where: www.heska.com (click on the ...link on the front page of this website)., Ho...

(Date:1/8/2009)...n. 8 St. Jude Children,s Research,...d that FedExCup Runner-Up,Camilo Villegas has inc...a,pledge to match Singh,s donation of $5,000 to S...TOUR. Eagles for St. Jude is a powerful program t...Singh and rising LPGA star Morgan,Pressel, along ...

Breaking Medicine News(10 mins):Health News:Veteran Environmental Health Expert Erik D. Olson to Join Pew 2 Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 2 Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 3 Health News:Webcast Alert: Heska Announces Fourth Quarter and Year-End 2008 Earnings Conference Call Webcast 2 Health News:Not to be Outdone by FedExCup Champion Vijay Singh, FedExCup Runner-Up Camilo Villegas Increases Commitment to Children of St. Jude 2 Health News:Not to be Outdone by FedExCup Champion Vijay Singh, FedExCup Runner-Up Camilo Villegas Increases Commitment to Children of St. Jude 3 Health News:Not to be Outdone by FedExCup Champion Vijay Singh, FedExCup Runner-Up Camilo Villegas Increases Commitment to Children of St. Jude 4

[0] Veteran Environmental Health Expert Erik D. Olson to Join Pew [0] Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference [0] Webcast Alert: Heska Announces Fourth Quarter and Year-End 2008 Earnings Conference Call Webcast [0] Not to be Outdone by FedExCup Champion Vijay Singh, FedExCup Runner-Up Camilo Villegas Increases Commitment to Children of St. Jude

...y conducted by the Mayo Clinic has revealed that a... Fibromyalgia is a disorder considered disabling ...ad musculoskeletal pain and symptoms such as fatig...ep disturbance. No cure is known and available tre...

...y has shown that reality was different from severa...pular misconception among both the young// and the...ccur when they're young in spite of research havin...equated with unhappiness for other people, individ...

...the study conducted by the Public Service Commissi...er of public servants believe HIV/AIDS is curable/... ere surveyed fall in to the category of very high...ey are measured on a scale from one to five, with ...

...the Malaysian Health Minister Chua Soi Lek the peo...sary. Hence he requested the people to cut down// ...tyle. According to the statistics Malaysians on an...veryday. This is extremely high as the health off...

Other Medicine News:Health News:Acupuncture to Relieve Fibromyalgia Symptoms 2 Health News:Attitudes About Aging Different from Reality 2 Health News:Attitudes About Aging Different from Reality 3

Acupuncture to Relieve Fibromyalgia Symptoms Attitudes About Aging Different from Reality Public Service in South Africa at a High Risk of Contracting AIDS Malaysian health minister asks to cut down the intake of sugar

(Date:1/7/2009)...ase , , WHITE PLAINS, N.Y., Jan. 7 /PRNewswire-...hat the decades-long rise in the United States pre...an ever at increased risk of death and disability ...,000 babies were born too soon in 2006, according ...h today released "Births: Final data for 2006," Na...

(Date:1/6/2009)...s from prior U.S., U.K. and China Trials , , SA...nc. (VTI), a development stage company targeting l...as begun for a randomized, controlled, multi-cente...acorporeal Liver Assist Device (ELAD) as a treatme...er three protocols. The study is open for enrollme...

(Date:1/6/2009).../ -- Cequent Pharmaceuticals, a pioneer in the dev...reatments to prevent and treat human disease, anno...ccessful toxicology study of its candidate CEQ501,...ting the primary oncogene (beta-catenin, CTNNB1) i...inherited gastrointestinal disease that causes hun...

(Date:1/5/2009)...wire/ -- Women undergoing in vitro,fertilization ...ort early,pregnancy, but the intramuscular inject...nful for patients. Formulations of progesterone m...us injection or vaginal suppository may offer,sim... With patient well-being a constant focus, Ferti...

Breaking Medicine Technology:Preterm Births Rise 36 Percent Since Early 1980s 2 ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 2 ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 3 Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 2 Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 3 Fertility Physicians of Northern California Researchers Test New Forms of Progesterone Medication for Luteal Support During IVF 2 UT Southwestern researchers create molecule that nudges nerve stem cells to mature 3639 1 UT Southwestern researchers create molecule that nudges nerve stem cells to mature 3639 2 UT Southwestern researchers create molecule that nudges nerve stem cells to mature 3639 3 A Health Gift for Men on Fathers Day 21866 1 A Health Gift for Men on Fathers Day 21866 2 Soliris 28R 29 Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis 2427 1 Soliris 28R 29 Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis 2427 2 Soliris 28R 29 Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis 2427 3 Soliris 28R 29 Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis 2427 4 Soliris 28R 29 Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis 2427 5 Soliris 28R 29 Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis 2427 6 Soliris 28R 29 Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis 2427 7 Soliris 28R 29 Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis 2427 8 Soliris 28R 29 Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis 2427 9 Novel model of osteosarcoma 21861 1

[1] Preterm Births Rise 36 Percent Since Early 1980s [0] ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers [2] Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference [2] Fertility Physicians of Northern California Researchers Test New Forms of Progesterone Medication for Luteal Support During IVF

...SBAD, CA, May 31, 2007 /PRNewswire-FirstCall/,- On..., Inc. today,announced that preliminary data from ...ted at the American Society of Clinical,Oncology A...ata,from a Phase II clinical study of OGX-011 in h...Phase I/II clinical study of,OGX-011 in non-small ...

...y of Gene Therapy in Lipoprotein Lipase,Deficiency..., 2007 - Amsterdam Molecular,Therapeutics (AMT), a...ed positive Phase I/II clinical trial results with...011) in Complete,Lipoprotein Lipase (LPL) deficien...can Society of Gene Therapy (ASGT) in Seattle.,The...

Other Medicine Technology:OncoGenex and Isis Announce OGX-011 Data to be Presented at ASCO 2 OncoGenex and Isis Announce OGX-011 Data to be Presented at ASCO 3 OncoGenex and Isis Announce OGX-011 Data to be Presented at ASCO 4 AMT Presents Positive Results of Phase I/II Study with Lead Product,at Annual Meeting of American Society of Gene Therapy 2 AMT Presents Positive Results of Phase I/II Study with Lead Product,at Annual Meeting of American Society of Gene Therapy 3 AMT Presents Positive Results of Phase I/II Study with Lead Product,at Annual Meeting of American Society of Gene Therapy 4

OncoGenex and Isis Announce OGX-011 Data to be Presented at ASCO AMT Presents Positive Results of Phase I/II Study with Lead Product,at Annual Meeting of American Society of Gene Therapy

...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...

Medicine Products:

Allergen, Food, Cheese, Cheddar Allergen, Food, Carrot Allergen, Food, Broccoli Allergen, Food, Beef

North America Primed for Pet Insurance Market Expansion and Expecting $1.1 Billi...(on this report from Packaged Facts visit...),Health